Study Of ATRN-119 In Patients With Advanced Solid Tumors

Clinical trial NCT04905914 · COMPLETED

Trial details

NCT number: NCT04905914
Sponsor: Aprea Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-01-09
Primary completion: 2026-03-09
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.